Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal for Immunotherapy of Cancer
|
March 15, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
Naveen K Mehta, Martin Pfluegler, Kristan Meetze, et al.
Journal of Hematology & Oncology
|
August 16, 2023
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Jonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.
Nature Communications
|
October 4, 2017
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
Melanie Märklin, Jonas S Heitmann, Alexander R Fuchs, et al.
Cancer Discovery
|
May 20, 2021
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Tatjana Bilich, Malte Roerden, Yacine Maringer, et al.
EMBO Molecular Medicine
|
December 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer
Latifa Zekri, Fabian Vogt, Lukas Osburg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Clinical Therapeutics
|
February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19
Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications
|
November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature
|
November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal for Immunotherapy of Cancer
|
March 15, 2022
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
Naveen K Mehta, Martin Pfluegler, Kristan Meetze, et al.
Journal of Hematology & Oncology
|
August 16, 2023
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Jonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.
Nature Communications
|
October 4, 2017
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
Melanie Märklin, Jonas S Heitmann, Alexander R Fuchs, et al.
Cancer Discovery
|
May 20, 2021
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Tatjana Bilich, Malte Roerden, Yacine Maringer, et al.
EMBO Molecular Medicine
|
December 29, 2020
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer
Latifa Zekri, Fabian Vogt, Lukas Osburg, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Frontiers in Immunology
|
December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S Heitmann, Susanne Jung, Marcel Wacker, et al.
Clinical Therapeutics
|
February 7, 2026
Phase I Study Evaluating a Monoclonal Fc-Silenced SARS-CoV-2 Antibody in Patients With Moderate-to-Severe COVID-19
Maddalena Marconato, Christopher Hackenbruch, Simon Jäger, et al.
Nature Communications
|
November 18, 2023
TOF<sub>IMS</sub> mass spectrometry-based immunopeptidomics refines tumor antigen identification
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature
|
November 23, 2021
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Jonas S Heitmann, Tatjana Bilich, Claudia Tandler, et al.
Page
of 7